{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:53:27Z","timestamp":1787169207739,"version":"build-2736575974"},"reference-count":88,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Due to the growing availability of imaging examinations the percentage of patients with incidentally diagnosed adrenal tumors has increased. The vast majority of these lesions are benign, non-functioning adenomas, although according to various estimates even up to 30%\u201350% of patients with adrenal incidentaloma may present biochemical hypercortisolemia, without typical clinical features of Cushing\u2019s syndrome. Adrenal adenomas secreting small amounts of glucocorticoids may cause morphological and functional changes in the myocardium and blood vessels. Early stages of cardiovascular remodeling may be observed among asymptomatic patients with adrenal adenoma. Vascular changes precede the development of cardiovascular diseases and can increase morbidity and mortality in patients with adrenal incidentaloma. This risk may result not only from the traditional risk factors. Seemingly hormonally inactive adrenal tumors can indeed produce small amounts of glucocorticoids that have metabolic implications. Therefore, evaluation of patients with incidental adrenal findings presenting with subclinical cardiovascular disease seems of particular importance.<\/jats:p>","DOI":"10.3390\/medicina56020069","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:25:21Z","timestamp":1581413121000},"page":"69","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma"],"prefix":"10.3390","volume":"56","author":[{"given":"Magdalena","family":"Szychli\u0144ska","sequence":"first","affiliation":[{"name":"Clinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-900 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Baranowska-Jurkun","sequence":"additional","affiliation":[{"name":"Clinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-900 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Matuszewski","sequence":"additional","affiliation":[{"name":"Clinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-900 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wo\u0142os-K\u0142osowicz","sequence":"additional","affiliation":[{"name":"Clinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-900 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Bandurska-Stankiewicz","sequence":"additional","affiliation":[{"name":"Clinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-900 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"ref_1","unstructured":"(2002). NIH state\u2013of\u2013the\u2013science statement on management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). NIH Consens State Sci. Statements, 19, 1\u201325."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.87.3.8277","article-title":"Adrenal incidentaloma: A new cause of the metabolic syndrome?","volume":"87","author":"Terzolo","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J. Endocrinol. Invest."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5603\/EP.a2016.0039","article-title":"Przypadkowo wykryty guz nadnercza (incydentaloma) u doros\u0142ych\u2014Zasady post\u0119powania rekomendowane przez Polskie Towarzystwo Endokrynologiczne","volume":"67","author":"Bednarczuk","year":"2016","journal-title":"Endokrynol. Pol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrendo.2010.235","article-title":"Adrenocortical carcinoma: A clinician\u2019s update","volume":"7","author":"Fassnacht","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1710990102","article-title":"Adrenocortical nodular hyperplasia: The ageing adrenal","volume":"99","author":"Dobbie","year":"1969","journal-title":"J. Pathol."},{"key":"ref_14","first-page":"204","article-title":"Receptors for insulin and insulin-like growth factor-I in the human adrenal gland. Biochem. Biophys","volume":"165","author":"Pillion","year":"1989","journal-title":"Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/07435809609043773","article-title":"Adrenal incidentalomas: A manifestation of the metabolic syndrome?","volume":"22","author":"Reincke","year":"1996","journal-title":"Endocr. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/JC.2015-1653","article-title":"Abnormal responsiveness to dexamethasone-suppressed CRH test in patients with bilateral adrenal incidentalomas","volume":"100","author":"Vassiliadi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrendo.2014.215","article-title":"Genetics of adrenal diseases in 2014: Genetics improves understanding of adrenocortical tumours","volume":"11","author":"Bertagna","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2013.10.028","article-title":"Genetics and epigenetics of adrenocortical tumors","volume":"386","author":"Lerario","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-17-0361","article-title":"Genetics of tumors of the adrenal cortex","volume":"25","author":"Bertherat","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_20","first-page":"242","article-title":"Features of metabolic syndrome in patients with adrenal incidentalomas","volume":"16","author":"Oszywa","year":"2014","journal-title":"Family Med. Primary Care Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing\u2019s syndrome: Controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/EJE-11-0601","article-title":"Increased myocardial fibrosis and left ventricular dysfunction in Cushing\u2019s syndrome","volume":"166","author":"Yiu","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_23","first-page":"1440","article-title":"Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: Clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.beem.2012.02.001","article-title":"Subclinical Cushing\u2019s syndrome","volume":"26","author":"Cozzolino","year":"2012","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing\u2019s syndrome: Update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.0.1470489","article-title":"Long-term follow-up study of patients with adrenal incidentalomas","volume":"147","author":"Libe","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.bjc.6602459","article-title":"Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas","volume":"92","author":"Bernini","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/eje.1.01959","article-title":"Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma","volume":"153","author":"Terzolo","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: An Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-09-0627","article-title":"The diagnosis of Cushing\u2019s syndrome: An Endocrine Society Clinical Practice Guideline: Commentary from a European perspective","volume":"163","author":"Guignat","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF03344133","article-title":"Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications","volume":"29","author":"Tsagarakis","year":"2006","journal-title":"J. Endocrinol. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1210\/jc.2009-1500","article-title":"Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing\u2019s syndrome","volume":"94","author":"Valassi","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2014.11.FOCUS14704","article-title":"Pitfalls in the diagnosis and management of Cushing\u2019s syndrome","volume":"38","author":"Bansal","year":"2015","journal-title":"Neurosurg. Focus."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2010-2722","article-title":"Clinical review: Diagnosis and treatment of subclinical hypercortisolism","volume":"96","author":"Chiodini","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MED.0000000000000151","article-title":"Subclinical hypercortisolism in adrenal incidentaloma","volume":"22","author":"Debono","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","article-title":"Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: A large cross-sectional study","volume":"166","author":"Vicennati","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_38","first-page":"12","article-title":"Cushing\u2019s Syndrome and Cardiovascular Risk","volume":"18","author":"Anagnostis","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1507\/endocrj.K07E-177","article-title":"Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing\u2019s syndrome","volume":"55","author":"Tsuiki","year":"2008","journal-title":"Endocr. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: A 15-year retrospective study","volume":"2","author":"Vicennati","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: An Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MED.0000000000000153","article-title":"Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes","volume":"22","author":"Pasquali","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/EJE-17-0047","article-title":"Cardiovascular events in patients with mild autonomous cortisol secretion: Analysis with artificial neural networks","volume":"177","author":"Morelli","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: A 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"key":"ref_46","first-page":"5301","article-title":"Body composition and metabolic features in women with adrenal incidentaloma or Cushing\u2019s syndrome","volume":"86","author":"Garrapa","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.metabol.2010.01.007","article-title":"Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: A cause-effect relationship?","volume":"59","author":"Peppa","year":"2010","journal-title":"Metabolism"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2796.2010.02291.x","article-title":"Adrenal incidentalomas and cardiometabolic morbidity: An emerging association with serious clinical implications","volume":"268","author":"Peppa","year":"2010","journal-title":"J. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"\u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: A cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2012.10.033","article-title":"Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: Findings from autopsy analysis","volume":"225","author":"Iwakiri","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group","volume":"340","author":"Polak","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.STR.32.2.454","article-title":"Association between arterial stiffness and atherosclerosis: The Rotterdam Study","volume":"32","author":"Grobbee","year":"2001","journal-title":"Stroke"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Rossi","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","article-title":"Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion","volume":"99","author":"Androulakis","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e37635","DOI":"10.5812\/ijem.37635","article-title":"The Relationship between Increased Epicardial Fat Thickness and Left Ventricular Hypertrophy and Carotid Intima-Media Thickness in Patients With Nonfunctional Adrenal Incidentaloma","volume":"14","author":"Imga","year":"2016","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","article-title":"Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis","volume":"37","author":"Tuna","year":"2014","journal-title":"J. Endocrinol. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"991","DOI":"10.12659\/MSM.897714","article-title":"Carotid Intima-Media Thickness as the Cardiometabolic Risk Indicator in Patients with Nonfunctional Adrenal Mass and Metabolic Syndrome Screening","volume":"22","author":"Evran","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_59","first-page":"57","article-title":"Markers of Subclinical Cardiovascular Disease in Nonfunctional Adrenal Incidentaloma Patients without Traditional Cardiovascular Risk Factors","volume":"125","author":"Cansu","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.endinu.2019.01.007","article-title":"Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome","volume":"66","author":"Emral","year":"2019","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.105.555235","article-title":"Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study","volume":"113","author":"Hofman","year":"2006","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2010.12.017","article-title":"Aortic Stiffness-Current Understanding and Future Directions","volume":"57","author":"Cavalcante","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12020-017-1439-6","article-title":"Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters","volume":"58","author":"Akkan","year":"2017","journal-title":"Endocrine"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/EJE-17-0986","article-title":"Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas","volume":"178","author":"Sbardella","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2003.09.042","article-title":"The relative importance of vascular structure and function in predicting cardiovascular events","volume":"43","author":"Fathi","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_67","first-page":"28","article-title":"Przebudowa serca na poziomie narz\u0105dowym","volume":"53","author":"Grajek","year":"2000","journal-title":"Defin. Klasyf. Kardiol. Pol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: Pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"495349","DOI":"10.4061\/2011\/495349","article-title":"Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications","volume":"2011","author":"Katholi","year":"2011","journal-title":"Int. J. Hypertens."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1053\/euhj.2000.2339","article-title":"Hypertensive heart disease. A complex syndrome or a hypertensive \u201ecardiomyopathy\u201d?","volume":"21","author":"Lip","year":"2000","journal-title":"Eur. Heart J."},{"key":"ref_71","first-page":"1287","article-title":"Population implications of ECG left ventricular hypertrophy","volume":"19","author":"Kannel","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1210\/jc.2003-030698","article-title":"Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk","volume":"88","author":"Iacobellis","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12020-013-0099-4","article-title":"Epicardial adipose tissue in endocrine and metabolic diseases","volume":"46","author":"Iacobellis","year":"2014","journal-title":"Endocrine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCULATIONAHA.107.743062","article-title":"Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: The Framingham Heart Study","volume":"11","author":"Rosito","year":"2008","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.ijo.0803726","article-title":"Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease","volume":"32","author":"Cheng","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2009.11.020","article-title":"Epicardial adipose tissue and coronary artery plaque characteristics","volume":"210","author":"Alexopoulos","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3945\/ajcn.2008.27358","article-title":"The association of pericardial fat with incident coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"90","author":"Ding","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjcard.2004.06.075","article-title":"Relation between epicardial adipose tissue and left ventricular mass","volume":"94","author":"Iacobellis","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF03346410","article-title":"Echocardiographic alterations in patients with non-functioning adrenal incidentaloma","volume":"31","author":"Ermetici","year":"2008","journal-title":"J. Endocrinol. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12020-013-9902-5","article-title":"Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma","volume":"44","author":"Iacobellis","year":"2013","journal-title":"Endocrine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.kjms.2017.04.002","article-title":"Comparison of echocardiographic findings in patients with nonfunctioning adrenal incidentalomas","volume":"33","author":"Imga","year":"2017","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_82","first-page":"656","article-title":"Assessment of Subclinical Cardiac Alterations and Atrial Electromechanical Delay by Tissue Doppler Echocardiography in Patients with Nonfunctioning Adrenal Incidentaloma","volume":"111","author":"Sokmen","year":"2018","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/vhrm.2005.1.4.291","article-title":"Cardiovascular consequences of cortisol excess","volume":"1","author":"Whitworth","year":"2005","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2009-2387","article-title":"Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism","volume":"95","author":"Chiodini","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing\u2019s syndrome","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surgery"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.surg.2007.10.001","article-title":"\u201cSubclinical Cushing\u2019s syndrome\u201d is not subclinical: Improvement after adrenalectomy in 9 patients","volume":"142","author":"Mitchell","year":"2007","journal-title":"Surgery"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: A systematic review and meta-Analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.surg.2016.07.042","article-title":"Outcome of adrenalectomy for subclinical hypercortisolism and Cushing syndrome","volume":"161","author":"Raffaelli","year":"2017","journal-title":"Surgery"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/2\/69\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:56:30Z","timestamp":1760172990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/2\/69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["medicina56020069"],"URL":"https:\/\/doi.org\/10.3390\/medicina56020069","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]}}}